ReviewWorld journal of surgery2003
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Review in World journal of surgery, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Association Between Alcohol Consumption and the Risk of Barrett's Esophagus: A Meta-Analysis of Observational Studies.Medicine · 2015Pooled it
- Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.World journal of gastroenterology · 2012Pooled it
- Statins as Potential Therapeutics for Esophageal Cancer.Journal of gastrointestinal cancer · 2021Review
- N-MYC Downstream Regulated Gene 4 (Cancers · 2020Article
- Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up.Digestive diseases and sciences · 2018Article
- Diagnosis and Management of Functional Heartburn.The American journal of gastroenterology · 2016Review
- Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma.Cancer research · 2014Article
- Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2014Article
- Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.The American journal of gastroenterology · 2013Article
- mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.British journal of cancer · 2012Article
- A substantial incidence of silent short segment endoscopically suspected esophageal metaplasia in an adult Japanese primary care practice.World journal of gastrointestinal endoscopy · 2012Article
- The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2011Article
- Diet composition affects surgery-associated weight loss in rats with a compromised alimentary tract.The Journal of surgical research · 2011Article
- Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Digestive diseases and sciences · 2010Article
- Article
- The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2010Article
- Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Gastroenterology · 2010Article
- Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.PloS one · 2010Article
- Medication usage and the risk of neoplasia in patients with Barrett's esophagus.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2009Article
- Barrett esophagus: histology and pathology for the clinician.Nature reviews. Gastroenterology & hepatology · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most available information on the epidemiology of Barrettacute;s esophagus (BE) relates to patients with long segments (> 3 cm) of specialized intestinal metaplasia (SIM). Its prevalence is 3% in patients undergoing endoscopy for reflux symptoms and 1% in those undergoing endoscopy for any clinical indication. The latter prevalence is similar to the 1% found in autopsy series. A "silent majority" with BE remain unrecognized in the general population. BE is more common in men, and the prevalence rises with age. Recent endoscopic series document a rise in the diagnosis of endoscopically apparent short segments (< 3 cm) of BE (SSBE). The prevalence of SSBE in both unselected and reflux patients is 8% to 12%. Specialized intestinal metaplasia at the cardia, below a normal-appearing squamocolumnar junction, has been reported to vary from 6% to 25% in patients presenting for upper endoscopy. Unlike patients with long segment Barrett's esophagus (LSBE), the role of gastroesophageal reflux disease in the pathogenesis of SSBE and SIM of the cardia is controversial. Recent data suggest that the etiology of SIM of the cardia might be secondary to Helicobacter pylori infection, although the role of other environmental factors cannot be ruled out. The incidence of adenocarcinoma of the esophagus and esophagogastric juction (EGJ) has been increasing over the past 15 years in Western countries. Surgical series and population-based studies show that by 1994 adenocarcinomas of the esophagus accounted for half of all esophageal cancer among white men. LSBE and SSBE predispose to the development of adenocarcinoma of the esophagus and EGJ. The role of SIM of the cardia as a precursor lesion for EGJ adenocarcinoma is still unclear. The prevalences of dysplasia in LSBE and SSBE are around 6% and 8%, respectively. The incidence of adenocarcinoma in patients with LSBE is about 1 in 100 patient-years. Cancer risk for SSBE and SIM at the cardia is unknown. Smoking and obesity increase the risk for esophageal and EGJ adenocarcinomas.
Indexed as
Identifiers
12917764What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.